drugset / Trial / NCT04983238
Evaluation of Safety and Efficacy of Sodium Thiosulfate (BYON5667) Eye Drops to Reduce Ocular Toxicity in Cancer Patients Treated With SYD985
RandomizedParallel-groupTriple-blindPrevention
Summary
This multicenter, randomized, double-blind, placebo-controlled trial with a single arm run-in period is to evaluate the safety and efficacy of sodium thiosulfate (BYON5667) eye drops to reduce ocular toxicity in cancer patients treated with the antibody-drug conjugate (ADC) SYD985
Timeline
- Start
- 2022-01-10
- Primary completion
- 2023-04-19
- Completion
- 2023-06-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BYON5667 | Unknown | — | Other |
| Background | Trastuzumab duocarmazine | Other / unclassified | — | Intravenous |